Questions and Answers regarding the Immunisation Schedule..

 

Why is the schedule being changed ?

 

The last full immunisation schedule change was in 1996.  Since then newer vaccines have become available that are safer and effective in controlling preventable diseases.  The oral polio vaccine is being replaced by the injectable inactivated polio vaccine which is given in conjunction with the DtaP.  The Ministry of Health is able to make this change as Dtap-IPV has been licensed and is available in New Zealand.  It is expected that this change will prevent the rare cases of vaccine-associated paralytic poliomyelitis in recipients and non-immune contacts.

The vaccinations that children will receive at four years of age will assist in preventing outbreaks of pertussis being spread through primary school aged children.

 Is immunisation compulsory ?

Immunisation is not compulsory in New Zealand and there are no plans of making it so.  However, immunisation is highly desirable and we strongly recommend that children are fully immunised before starting school.  There is research showing that unimmunised children spread these infections to younger family members.  Schools are required to ask parents to show each new entrant's Immunisation Certificate and to keep an immunisation register.  Information on the Certificates is given in a pamphlet entitled "Immunisation Certificates - Information for Primary Schools" which all schools have.  Parents and caregivers have the right to make informed choices about immunisation.  They need reliable information about the nine diseases which immunisation protects against, and the effectiveness and side effects of the vaccines.

Immunisation if free, and protects against measles, mumps, rubella, polio, whooping cough, diphtheria, tetanus, Heamophilus influenza (Hib) and Hepatitis B.  Research has proven the risk of complications form catching these diseases is far greater than the side effects from vaccines.

 

COMMONLY ASKED QUESTIONS ABOUT IMMUNISATION

 

'Vaccines do not work as most cases of the disease are in immunised children'

 

No vaccine is 100% effective and some immunised children will get the disease.  As immunisation coverage increases the proportion of cases who are immunised will increase.  There is a simple relation between vaccine efficacy, immunisation coverage and the proportion of cases who are immunised.  Imagine a group of 100 children.  If 90% of children are given a vaccine that is 90% effective, that means that 81 of the 100 will be immune.  So 10 children will be susceptible from not having the vaccine and another 9 from vaccine failure.  So, nearly half the cases of disease will be in immunised children - even though only 10% of immunised children were susceptible.

 'Immunisations are not needed in industrialised countries'

 Many diseases prevented by immunisation are spread directly from human to human therefore clean water and good hygiene do not stop all infections (e.g. measles, pertussis).  Despite excellent hospital care, long term complications and death still occur from diseases that can be prevented by immunisation.  While it is true that the impact of immunisation is greater in less developed countries, it remains important for New Zealand children.

  

'Natural immunity better than vaccine-induced immunity'

 

No.  Although protective antibody levels tend to be higher after disease than immunisation this does not necessarily mean that natural immunity is better.  There is more to immunity than antibody levels.

Natural immunity and vaccine-induced immunity are both natural responses of the body's immune system.  The body's immune response in both circumstances is virtually the same.  The problem is that with 'natural' disease, your child runs the risks of serious illness, disability and death to get immunity.  In contrast, immunity from vaccine is at a much lower risk.  However, several doses of the vaccine (as well as Booster doses) may be needed to achieve and maintain good levels of immunity.  Immunisation does not always produce immunity.

  

'A healthy lifestyle will protect children from infection'

A healthy lifestyle does not produce the necessary immune response to protect a child from serious infection.  Only immunisation or actually catching the disease can do this. 

 Immunisation poses far less risk than catching the infection and maintains the health of the child.

The living arrangements of a person (e.g. overcrowding, in adequate sanitation and hygiene) will affect the likelihood of being exposed to an infection.  The health of a person makes little difference as to whether they will get an infection if exposed.  However, a child who is in good health will be much less likely to suffer a severe illness, or to have complications.

A healthy lifestyle does not provide secure protection against disease or its complications.   For example, over half of all the children who died from measles in the UK between 1970 and 1983 were previously healthy (Miller 1985).  In the 1991 measles epidemic in New Zealand there were seven deaths, five children, and two.  No other contributing condition was listed in the death certificates.

 

'Homoeopathic immunisation prevents infection'

Homeopathic 'immunisation' offers no proven protection against infectious diseases.  Dr Hahnemann, the founder of homeopathy, considered conventional immunisation to be 'a clear and convincing demonstration of the Law of Similitude' - the fundamental principle of homeopathy (Fisher 1990).  The UK Faculty of Homeopathy supports conventional immunisation and is not aware of any evidence supporting the use of homeopathic immunisation (English 1992).

Some non-medical homeopaths do not support conventional immunisation and state that homeopathic preparations can prevent disease.  There are no published studies to support such beliefs.  In addition, an extensive review of homeopathic studies found none on the prevention of the immunisation schedule diseases (Kleijnen et at 1991).  There were some studies on the prevention of influenza, with all but one showing no effect.  The one study that did find a protective effect was rated as 'poor quality'.

Only conventional immunisation has been shown to produce a measurable immune response and protection against disease.

 

'Vaccines contain toxic chemicals, viruses and cells'

The production of a vaccine is highly regulated, with a requirement for extensive testing during manufacture and of the final product.  The manufacturer must show that each dose if safe, pure, and potent enough to be effective.  Any toxic substances (e.g. formaldehyde) that are present can only be in very small amounts, considerably less than are likely to do any harm to a baby.

There have been unwanted viruses in vaccines in the past: such as SV40 in polio vaccines in the 1950s and Pestivirus in some Japanese vaccines in the 1980s.  All vaccines are carefully tested now to ensure that there are no other viruses or bacteria present.  The sophistication of this testing continues to improve.

In 1995, there was concern at the finding of an enzyme (reverse transcriptase) in vaccines grown in chick cells that could have come from a previously unidentified virus.  The finding was from a new test that was a million times more sensitive than the old test.  Further work has identified the source of this enzyme as from the chick cell that the vaccine is grown in, rather than any virus (Anonymous 1998).

Some vaccines (e.g. rubella) are grown in cells of human origin.  The starting material for some of these cells was from foetuses aborted for medical reasons in the 1960s.  By a process of repeated cultivation it is possible to produce an 'immortal' self-replicating group of cells known as a 'cell line'.  A cell line is similar but not identical to the original cell.  Apart from the origin of the cell there is no other connection to any foetus.  The cell line can be maintained indefinitely in the laboratory and provides a safe and standardised medium for growing vaccine viruses.

Whether the vaccines are grown on cells of human or animal origin, the cells are not in the final vaccine.  Once the vaccines have been grown on the cells, they are separated from the cells, and all the cells' materials are removed.  It is possible that minute traces of parts of these cells would remain in the vaccine, but it would not be possible for any whole cells to be in the vaccine.

  

'Vaccines may cause mad cow disease' 

The materials used in some vaccines could, in theory, transmit Bovine Spongiform Encephalopathy (BSE) or mad cow disease or its human equivalent variant Creutzfeld-Jakob Disease (vCJD).  After billions of doses of use, this has not been documented.  In addition, for those vaccines that use material from cows (e.g. Hib vaccine) the manufacturer must ensure that these materials come from BSE free areas and that it is purified to reduce any risk.  There is also a theoretical risk from vaccines that use human blood products such as albumin (e.g. MMR).  Again, this has never been demonstrated.  In addition, there is no evidence of transmission of vCJD from blood products.

 

'Vaccines viruses persist after immunisation'

Vaccine viruses are supposed by some opponents of immunisation to persist in the body leading to chronic disease.  There is no evidence that constituents of vaccines persist after immunisation.  Varicella vaccine (chickenpox) does persist after immunisation and may rarely cause shingles.  Varicella is not currently on the New Zealand immunisation schedule.

 

'MMR can cause autism and inflammatory Bowel Disease'

Recent studies proposed that the measles vaccine is linked with inflammatory bowel disease and autism whilst other reports have found no such association.  The recently released Institute of Medicine report from the Immunisation Safety Review Committee, MMR and Autism in the US, concluded that the evidence does not support, at the population level, a causal relationship between the MMR vaccine and autistic spectrum disorders (ASD).  The Committee does not exclude the possibility that the MMR vaccine could contribute at ASD in a small number of  children.  This is because of the difficulty of assessing a rare occurrence and proposed biological models have not been disproved (Institute of Medicine 2001).  The committee did not recommend any review of licensure of MMR or change in the programme in the US.

 

'My child is allergic'

Only anaphylaxis is considered a contraindication or precaution for immunisation.  Children with asthma, eczema, hay fever and simple allergies should be immunised in the usual way.  Egg allergy is no longer considered a contraindication to vaccination (Khaakoo 2000).  Other components of the vaccine, for example gelatine, may be responsible for the allergic reactions (Nakayama et al 1999).

 

References

Miller C.L. 1985.  Deaths from measles in England and Wales.  1970-83.

British Medical Journal 290: 443-4.

Fisher P. 1990.  Enough nonsense on immunisation. 

British Homeopathic Journal 79:198-200. - The Fundamental Principle of Homeopathy.

 

English J. 1992.  The Issue of Immunisation.

British Homeopathic Journal 1992; 81: 161-3.

 

Kleijnen J, P. Knipschild P, ter Riet G. 1991.  Clinical trials of homeopathy.

British Medical Journal 302:316-23.

 

Anonymous.  1998.  Reverse transcriptase activity in chicken-cell derived vaccine.

Weekly Epidemiology Rec 73: 209-12.

 

Institute of Medicine.  2001.  Immunisation Safety Review Committee:  MMR and Autism.

 

Khaakoo GA.  Lack G. 2000.  Recommendations for using MR vaccine in children allergic to eggs.

British Medical Journal 320: 929-932.

 

Nakayama T, Aizawa C, Kuno-Sakai H. 1999.  A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.

Journal of Allergy Clinical Immunology 103: 321-5.

 

For more information contact:

 

1.  The Ministry of Health Website www.moh.govt.nz

2.  0800 IMMUNE (0800 466 863), or see the Immunisation Advisory Centre website

     www.imac.auckland.ac.nz

3.  Your local Immunisation coordinator or Public Health Service.  

4. The practice nurse at the clinic: 578-1665